Baseline Predictors of Poor Outcome in Patients Too Good to Treat With Intravenous Thrombolysis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Stroke

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.116.014871PMID 27834750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Should Minor Stroke Patients Be Thrombolyzed? A Focused Review and Future Directions

  2015cited by this paper
• Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care.

  2015cited by this paper
• Relationship of National Institutes of Health Stroke Scale to 30-Day Mortality in Medicare Beneficiaries With Acute Ischemic Stroke

  2012cited by this paper
• Too Good to Treat? Outcomes in Patients Not Receiving Thrombolysis Due to Mild Deficits or Rapidly Improving Symptoms

  2012cited by this paper
• Mild stroke and rapidly improving symptoms: it's not always a happy ending.

  2011cited by this paper
• Risk Score for In-Hospital Ischemic Stroke Mortality Derived and Validated Within the Get With The Guidelines–Stroke Program

  2010cited by this paper
• Strokes With Minor Symptoms: An Exploratory Analysis of the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trials

  2010cited by this paper
• Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke: A Metaanalysis

  2009cited by this paper
• Reasons why few patients with acute stroke receive tissue plasminogen activator.

  2006cited by this paper
• Early MRI and outcomes of untreated patients with mild or improving ischemic stroke

  2006cited by this paper
• Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.

  2005cited by this paper
• Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke

  2005cited by this paper
• Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

  2004cited by this paper
• Cardiac Autonomic Derangement and Arrhythmias in Right-Sided Stroke With Insular Involvement

  2004cited by this paper
• Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey.

  2001cited by this paper
• Why are stroke patients excluded from TPA therapy?

  2001cited by this paper
• Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility

  2001cited by this paper
• Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

  2000cited by this paper
• Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group.

  1999cited by this paper
• Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey

  1999cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group

  1995cited by this paper
• Vascular Health and Risk Management Dovepress Current Perspectives on the Use of Intravenous Recombinant Tissue Plasminogen Activator (tpa) for Treatment of Acute Ischemic Stroke

  year unknowncited by this paper

• Predictors of clinical outcome in post-thrombolysis among sample of Egyptian patients with acute ischemic stroke

  2025influential citation
• Navigating the Waters of Acute Minor Stroke Therapies: A Systematic Review and Network Meta-analysis.

  2025cites this paper
• Comparison of psychometric properties of the dual-task timed up-and-go test (cognitive) and the 3-m walk backward test in community-dwelling stroke patients

  2024cites this paper
• Intravenous thrombolysis versus dual antiplatelet therapy for patients with acute minor ischaemic stroke: a systematic review and meta-analysis

  2024cites this paper
• Factors predicting functional outcome after rtPA for patients with acute ischemic stroke

  2024cites this paper
• IV Thrombolysis vs Early Dual Antiplatelet Therapy in Patients With Mild Noncardioembolic Ischemic Stroke

  2023cites this paper
• Computed tomography perfusion imaging-guided intravenous thrombolysis in acute minor ischemic stroke

  2023cites this paper
• Feasibility of a Clinical-Radiomics Model to Predict the Outcomes of Acute Ischemic Stroke

  2022cites this paper
• The potential role of insulin resistance in predicting outcome from intravenous thrombolytic therapy

  2022cites this paper
• Application of Network Analysis to Uncover Variables Contributing to Functional Recovery after Stroke

  2022cites this paper
• Progressive Lacunar Atrokes: A Predictive Score.

  2022cites this paper
• Intravenous thrombolysis in stroke with admission NIHSS score 0 or 1

  2021cites this paper
• Risk Factors of Hypoperfusion on MRI of Ischemic Stroke Patients Within 7 Days of Onset

  2021cites this paper
• Frequency and Prognostic Significance of Clinical Fluctuations Before Hospital Arrival in Stroke

  2021cites this paper
• Prediction-Driven Decision Support for Patients With Mild Stroke: A Model Based on Machine Learning Algorithms

  2021cites this paper
• Outcome predictors of intravenous thrombolytic therapy in acute ischemic stroke patients: an Egyptian center experiences

  2020cites this paper
• Progression of stroke deficits in patients presenting with mild symptoms: The underlying etiology determines outcome

  2020cites this paper
• Door to needle time and functional outcome for mild ischemic stroke over telestroke

  2019cites this paper
• Predictors of poor outcome in embolic stroke of undetermined source

  2019cites this paper
• Disability after minor stroke and TIA

  2019cites this paper
• Indications for Mechanical Thrombectomy Too Wide or Too Narrow?

  2019cites this paper
• Absence of Collaterals is Associated with Larger Infarct Volume and Worse Outcome in Patients with Large Vessel Occlusion and Mild Symptoms.

  2019cites this paper
• Higher Platelet-to-Lymphocyte Ratio Is Associated With Worse Outcomes After Intravenous Thrombolysis in Acute Ischaemic Stroke

  2019cites this paper
• Recurrent thrombolysis of a stuttering lacunar infarction captured on serial MRIs

  2018cites this paper
• [The experience of using thrombolysis in patients with acute disturbances of cerebral circulation: efficacy, safety, predictors of outcome and hemorrhagic transformation].

  2018cites this paper
• The American Heart Association’s Get With the Guidelines (GWTG)-Stroke development and impact on stroke care

  2017cites this paper
• Is Reperfusion Useful in Ischaemic Stroke Patients Presenting with a Low National Institutes of Health Stroke Scale and a Proximal Large Vessel Occlusion of the Anterior Circulation?

  2017cites this paper
• Minor Stroke and Thrombolysis: What Is in the Pipeline?

  2017cites this paper
• Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries

  2017cites this paper